One of the world’s most trusted pharmaceutical names, Johnson & Johnson (J&J), is facing a colossal legal challenge right here in the UK. Hundreds of women are banding together to launch a group action, alleging a devastating link between the company’s talcum powder and a diagnosis of ovarian cancer.
If this fight goes ahead, it is set to become the largest pharmaceutical product group action in the legal history of England and Wales, with lawyers already identifying 1,900 potential claimants including patients, survivors, and affected families.
The Alleged Cover-Up
The core of the legal horror story is the claim that for decades, J&J’s talcum powder was contaminated with asbestos, a well known carcinogen, and that the company was allegedly aware of this contamination but sought to hide the information.
For women like Cassandra Wardle from Derbyshire, the product was a lifelong staple. Diagnosed with cancer in 2021, she felt “enraged that a corporate giant like J&J could seem to do this,” particularly after reading about the potential links while beginning her chemotherapy journey.
Cassandra’s story, while a survival one, is a reminder of the personal cost. After being told her cancer was terminal, she was forced to close her business, suffered vocal cord damage, and had a hysterectomy that plunged her into surgical menopause.
“I would have liked children,” she explains. “My last ability to have children was taken away due to cancer.”
The story is echoed by Deborah (name changed), also from Derbyshire, who was diagnosed with ovarian cancer at just 29. Within two weeks of her first symptom, she had a full hysterectomy. “I went from excitedly planning for a baby to having all of my parts removed,” she recalls.
J&J’s Multi-Billion Pound Problem
While J&J vehemently denies suppressing any information and maintains its talc products are safe, the sheer scale of the global litigation is undeniable.
In the US, the company has faced over 62,000 lawsuits. Now, J&J is attempting to draw a line under the conflict by putting forward its third massive settlement offer, dedicating $6.475 billion (around £5.2 billion) over 25 years to resolve the majority of ovarian cancer claims. The company is trying to appeal directly to the claimants, arguing that the slow nature of the legal system means most of those affected would otherwise never get their “day in court.”
As the UK lawyers push ahead, J&J’s Worldwide Vice President of Litigation, Erik Haas, insists the allegations “defy logic, rewrite history and ignore the facts.” He states the company has always been “entirely transparent” with testing.
However, the UK case is gaining momentum, and lawyers warn they are “walking into a wave of women reaching an age where asbestos cancers develop.” For claimants like Linda Jones, 66, who has stage four cancer, the concern is simply running out of time before the long, drawn out litigation process concludes.
J&J stopped UK sales of its talc based baby powder last year (having moved to cornstarch) but this enormous legal battle suggests the financial and reputational damage of its decades old flagship product is far from over.
Related Topic: Health
